Summary
Epidermal growth factor (EGF) stimulated prostacyclin (PGI2) production by cultured human umbilical vein endothelial cells, as measured by radioimmunoassay
of its stable metabolite 6-keto- prostaglandin Flα. This effect of EGF was dose-dependent, the lowest stimulatory concentration of EGF
was 1.0 ng/ml and 100 ng/ml caused a 2.7 ± 0.3 (mean ± SEM) fold increase in the PGI2 synthesis. The stimulation appeared at 3-6 h of incubation and lasted at least 24
h. It was suppressed by EGF antibodies and blocked by protein synthesis inhibitor
cycloheximide. Cells preincubated 12 h with EGF released also higher amounts of PGI2when incubated with thrombin for 5 min. It is concluded that EGF liberated from platelets
during aggregation may prevent local thrombogenesis and atherogenesis by stimulating
the release of the antiaggregatory, vasodilatory PGI2 from vascular endothelial cells.
Keywords
(Human) Endothelial cells - Epidermal growth factor - Prostacyclin